The roles of histamine and its receptor ligands in central nervous system disorders: An update

被引:86
|
作者
Hu, Weiwei [1 ]
Chen, Zhong [1 ]
机构
[1] Zhejiang Univ, Dept Pharmacol, Key Lab Med Neurobiol,Sch Med, Minist Hlth China,Sch Basic Med Sci,Coll Pharmace, Hangzhou 310058, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; Cerebral ischemia; Histamine; Histamine receptor; Parkinson's diseases; Sleep disorders; Schizophrenia; POSITRON-EMISSION-TOMOGRAPHY; MODERATE ALZHEIMERS-DISEASE; LEVODOPA-INDUCED DYSKINESIA; L-HISTIDINE DECARBOXYLASE; FOCAL CEREBRAL-ISCHEMIA; KNOCKOUT HDC(-/-) MICE; P-GLYCOPROTEIN EFFLUX; RAT PC12 CELLS; H-3; RECEPTOR; PARKINSONS-DISEASE;
D O I
10.1016/j.pharmthera.2017.02.039
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The neurotransmitter histamine receives less attention compared with other biogenic amines, because of its moderate action in the central nervous system (CNS). However, recent evidence suggests that histamine plays an important role in multiple CNS disorders including insomnia, narcolepsy, Parkinson's diseases, schizophrenia, Alzheimer's disease, and cerebral ischemia. New insights are emerging into the potential roles of histamine receptors as targets for the treatment of these diseases. Although some histamine related agents have failed in clinical trials, current preclinical studies suggest that this neurotransmitter may still have extensive applications in treating CNS disorders, however, advanced studies are warranted. This review summarizes findings from animal models and clinical research on the role of histamine and its receptor ligands in the brain for treatment of CNS disorders. The development of novel histamine receptor ligands and gaining an in-depth understanding of their potential mechanisms are necessary stepping stones to unlock their wide-ranging applications in the clinical arena. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:116 / 132
页数:17
相关论文
共 50 条
  • [11] Protective and Regenerative Roles of T Cells in Central Nervous System Disorders
    Evans, Frances L.
    Dittmer, Marie
    Denise, Alerie G. de la Fuente
    Fitzgerald, Denise C.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [12] Reactive Astrocytes and Emerging Roles in Central Nervous System (CNS) Disorders
    Liddelow, Shane A.
    Olsen, Michelle L.
    Sofroniew, Michael V.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2024, 16 (07):
  • [13] The Roles of Lpar1 in Central Nervous System Disorders and Diseases
    Xiao, Dongqiong
    Su, Xiaojuan
    Gao, Hu
    Li, Xihong
    Qu, Yi
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [14] Histamine, antihistamines, and the central nervous system
    Lieberman, Philip
    ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (05) : 482 - 486
  • [15] HISTAMINE IN CENTRAL NERVOUS-SYSTEM
    GREEN, M
    PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY, 1978, 21 : 337 - 339
  • [16] ON FUNCTION OF HISTAMINE IN CENTRAL NERVOUS SYSTEM
    STERN, P
    IGIC, R
    NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1969, 263 (01): : 253 - &
  • [17] Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
    Parsons, Matthew P.
    Raymond, Lynn A.
    NEURON, 2014, 82 (02) : 279 - 293
  • [18] Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system
    Witkin, JM
    Nelson, DL
    PHARMACOLOGY & THERAPEUTICS, 2004, 103 (01) : 1 - 20
  • [19] Apelin, and its receptor within the central nervous system
    Wawrzyniak-Gacek, Agata
    MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE, 2011, 67 (06): : 390 - 393
  • [20] Widening the spectrum of inflammatory disorders of the central nervous system: an update on autoimmune neurology
    Graus, Francesc
    CURRENT OPINION IN NEUROLOGY, 2019, 32 (03) : 449 - 451